Verum Health
Longevity Protocol

Epitalon / GHK-Cu · 5ML

Epitalon (Epithalon) is a tetrapeptide studied for telomerase activation, anti-aging, and longevity. Often combined with GHK-Cu for synergistic regenerative effects. Physician-reviewed. Prescription required.

Longevity Anti-Aging Prescription Required
What It Is
Epithalon 5ML

Mechanism of Action

Epithalon is a synthetic peptide derived from the naturally occurring epithalamin produced by the Pineal gland. Its primary mechanism of action is associated with telomere regulation and anti-aging effects, as well as modulation of neuroendocrine and antioxidant pathways. GHK-Cu is a naturally occurring copper-binding tripeptide derived from the peptide GHK, acting as a signaling and copper-transport molecule that influences tissue repair, inflammation, and gene expression.

When combined, Epithalon and GHK-Cu form a synergistic longevity stack targeting telomere maintenance, cellular regeneration, and tissue repair signaling. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.

Epitalon 5ML
Mechanism Biological Effect
Telomerase activation (TERT) Maintenance of telomere length
Pineal/neuroendocrine modulation Improved melatonin and circadian rhythms
Antioxidant effects Reduced ROS, DNA protection
Gene/epigenetic regulation Enhanced DNA repair
Immune modulation Support for lymphocyte function
GHK-Cu 5ML
Mechanism Biological Effect
Copper chelation and delivery Activates copper-dependent enzymes
Gene expression modulation Promotes regenerative pathways
Fibroblast activation Increases collagen and elastin
Anti-inflammatory signaling Suppresses NF-κB cytokine pathways
Antioxidant effects Reduces oxidative stress
Angiogenesis and remodeling Accelerates tissue repair
Candidate Profile

Who It's Designed For

Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with Epitalon / GHK-Cu protocol candidates in clinical practice:

Longevity Protocol

Individuals pursuing physician-supervised telomere and anti-aging support.

Cellular Anti-Aging

Individuals seeking physician-reviewed oxidative stress reduction and DNA repair support.

Circadian Optimization

Individuals with sleep or circadian dysregulation where pineal modulation may be relevant.

Combination Longevity Stack

Patients combining Epitalon with GHK-Cu or NAD+ in a physician-reviewed longevity protocol.

Determine your candidacy

A physician will review your intake and make eligibility determination within 24–48 hours.

Outcomes & Timeline

What the Clinical Literature Indicates

All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.

Days 1–5
Initial neuroendocrine modulation. Sleep and circadian effects may be observed early. Individual outcomes vary.
Days 5–10
Antioxidant and DNA protection mechanisms active with continued administration.
Post-Cycle
Effects of Epitalon cycles may persist beyond the administration period. Follow-up physician review recommended.
Dosing Overview

Protocol Structure

Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.

Typical Range

5–10 mg/day (Epitalon); 1–10 mg/day (GHK-Cu)

Administration

Subcutaneous injection (physician-determined)

Duration

10–20 days per cycle; 2–3x/year

Frequency

Once daily during cycle (physician-determined)

These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.

What's Included

Your Protocol Package

Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD

Valid prescription — Issued by your attending physician upon protocol approval

Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner

Follow-up check-in — Physician review at protocol midpoint; reorder pathway established

Clinical Considerations

Contraindications & Safety Notes

Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.

History of malignancy: Discuss with your physician. Angiogenic or growth-promoting peptides are reviewed carefully in cancer history contexts.
Pregnancy or lactation: Not indicated. Clinical use is contraindicated in pregnant or nursing individuals.
Current medications: Potential interactions reviewed during physician consultation. Disclose all medications and supplements during intake.
Autoimmune conditions: Reviewed case-by-case. Immunomodulating peptides require careful physician assessment.
FAQ

Common Questions

This compound is not FDA-approved as a drug. It is dispensed as a compounded medication through licensed 503A compounding pharmacies operating under FDA guidelines. All Verum Health protocols require a valid physician prescription.
After completing your HIPAA-secure health intake, a physician or NP will review your medical history, current medications, goals, and contraindications. If you're a candidate, a virtual consultation is scheduled — typically 15–20 minutes. Turnaround is 24–48 hours from intake submission.
Protocol stacking is reviewed on a case-by-case basis during your physician consultation. Any combination protocol is evaluated for safety and clinical appropriateness. Do not combine protocols without explicit physician guidance.
Reorders are managed through your patient portal. A follow-up physician check-in is required at protocol completion before continuation is authorized. Reorder notification is sent 10 days before your protocol completes.
Epithalon
VERUM HEALTH
From $160
Prescription required
Begin Consultation
How it works:
Add to cart → complete physician intake → doctor reviews within 24–48h → approval → pharmacy ships direct.
Refill Policy: Approved protocols include 4 months of refills. Auto-refill available after initial approval.